Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David van Duin

Showing results (21-30 of 204) with videos related to

Pageof 21
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2025
The Antibiotic Pipeline Has Delivered for Drug-Resistant Gram-Negative Pathogens, Now Global Access Must FollowJason M Pogue, David van Duin
Expert Review of Anti-Infective Therapy|January 6, 2024
Reviewing novel treatment options for carbapenem-resistant <i>Enterobacterales</i>Natalie A Mackow, David van Duin
Jac-Antimicrobial Resistance|June 30, 2021
The impact of the COVID-19 pandemic on antimicrobial resistance: a debateDavid van Duin, Gavin Barlow, Dilip Nathwani
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2024
Cytomegalovirus Disease: Fine-Tuning Clinical Trial Enrollment and StandardizationJennifer M Cuellar-Rodriguez, David van Duin
Emerging Infectious Diseases|April 8, 2011
Cytomegalovirus viremia, pneumonitis, and tocilizumab therapyDavid van Duin, Cyndee Miranda, Elaine Husni
American Journal of Hematology|October 2, 2019
Preventing infectious complications when treating non-malignant immune-mediated hematologic disordersLuis Malpica, David van Duin, Stephan Moll
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 2, 2023
Which trial do we need? How to treat Pseudomonas aeruginosa bacteraemia-proposal for an umbrella randomized controlled trialMayan Gilboa, David van Duin, Dafna Yahav
Jac-Antimicrobial Resistance|April 27, 2023
Impact of childhood malnutrition and intestinal microbiota on MDR infectionsThomas Holowka, David van Duin, Luther A Bartelt
Antimicrobial Agents and Chemotherapy|October 18, 2002
Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofunginDavid van Duin, Arturo Casadevall, Joshua D Nosanchuk
Frontiers in Medicine|February 12, 2021
Antimicrobial Resistance in <i>Enterobacterales</i> and Its Contribution to Sepsis in Sub-saharan AfricaKathleen Tompkins, Jonathan J Juliano, David van Duin
Pageof 21

Showing results (21-30 of 204) with videos related to

Sort By:
Pageof 21
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 29, 2025
The Antibiotic Pipeline Has Delivered for Drug-Resistant Gram-Negative Pathogens, Now Global Access Must FollowJason M Pogue, David van Duin
Expert Review of Anti-Infective Therapy|January 6, 2024
Reviewing novel treatment options for carbapenem-resistant <i>Enterobacterales</i>Natalie A Mackow, David van Duin
Jac-Antimicrobial Resistance|June 30, 2021
The impact of the COVID-19 pandemic on antimicrobial resistance: a debateDavid van Duin, Gavin Barlow, Dilip Nathwani
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2024
Cytomegalovirus Disease: Fine-Tuning Clinical Trial Enrollment and StandardizationJennifer M Cuellar-Rodriguez, David van Duin
Emerging Infectious Diseases|April 8, 2011
Cytomegalovirus viremia, pneumonitis, and tocilizumab therapyDavid van Duin, Cyndee Miranda, Elaine Husni
American Journal of Hematology|October 2, 2019
Preventing infectious complications when treating non-malignant immune-mediated hematologic disordersLuis Malpica, David van Duin, Stephan Moll
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 2, 2023
Which trial do we need? How to treat Pseudomonas aeruginosa bacteraemia-proposal for an umbrella randomized controlled trialMayan Gilboa, David van Duin, Dafna Yahav
Jac-Antimicrobial Resistance|April 27, 2023
Impact of childhood malnutrition and intestinal microbiota on MDR infectionsThomas Holowka, David van Duin, Luther A Bartelt
Antimicrobial Agents and Chemotherapy|October 18, 2002
Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofunginDavid van Duin, Arturo Casadevall, Joshua D Nosanchuk
Frontiers in Medicine|February 12, 2021
Antimicrobial Resistance in <i>Enterobacterales</i> and Its Contribution to Sepsis in Sub-saharan AfricaKathleen Tompkins, Jonathan J Juliano, David van Duin
Pageof 21